Institutional Ownership
Arena Pharmeceuticals Inc
CUSIP 040047607COMMON STOCKARNAEURQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
10.8%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Mar 11, 2022
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 11, 2022 | Blackrock Inc. | 13G/A | 7.9% | 4.86M | SEC |
| 2 | Feb 11, 2022 | Avoro Capital Advisors LLC | 13G/A | 2.0% | 1.24M | SEC |
| 3 | Feb 9, 2022 | Vanguard Group Inc | 13G/A | 9.3% | 5.71M | SEC |
| 4 | Feb 8, 2022 | Blackrock Inc. | 13G | 7.9% | 4.86M | SEC |
| 5 | Feb 4, 2022 | Wellington Management Group LLP | 13G/A | 6.3% | 3.88M | SEC |
| 6 | Feb 12, 2021 | Avoro Capital Advisors LLC | 13G | 7.2% | 4.19M | SEC |
| 7 | Feb 10, 2021 | Vanguard Group Inc | 13G/A | 9.1% | 5.26M | SEC |
| 8 | Jan 29, 2021 | Blackrock Inc. | 13G/A | 9.3% | 5.39M | SEC |
| 9 | Jan 11, 2021 | Wellington Management Group LLP | 13G/A | 10.8% | 6.29M | SEC |
| 10 | Apr 9, 2020 | Blackrock Inc. | 13G/A | 10.1% | 5.10M | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Arena Pharmeceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $100 |